Home
Series of Journals
Literature
Latest literature
Popular literature
About us
Intro
Organizational structure
Editor in Chief
Copyright
Contact us
The title
The title
The keywords
The author
Wuhan University
Zhongnan Hospital of Wuhan University
Center for Evidence-Based and Translational Medicine of Wuhan University
Home
Results
The title
The title
The keywords
The author
A total of
17
result was found. Results that relate to
Chemotherapy
Chemotherapy for 3 cases of shock caused by macrophage activation syndrome secondary to adult-onset Still’s disease and an associated literature review
Published on
New Medicine
2021,31(1):390-394.
4389 times
2574 times
Wen-Yan XIAO
Tian-Feng HUA
Yao ZHENG
Hui LI
Min YANG
Chemotherapy
Adult-onset Still’s disease
Macrophage activation syndrome
Shock
Details
Pathological features of HER-2 hypoexpression breast cancer and its effect on neoad-juvant chemotherapy
Published on
Journal of Mathematical Medicine
2023,36(4):282-287.
2255 times
694 times
Jing WANG
Nan WANG
Xian-Hua QIU
Breast cancer
HER-2
Clinicopathological features
Neoadjuvant chemotherapy
Details
Analysis of five-step nutrition combined with CAPEOX chemotherapy in patients with postoperative adjuvant chemotherapy for colorectal cancer
Published on
Journal of Mathematical Medicine
2023,36(5):352-357.
2139 times
550 times
Zhen FENG
Fang ZHOU
Han HU
Guo-Wu QIAN
CAPEOX
Chemotherapy
Five-step nutrition
Colorectal cancer
Adjuvant chem-otherapy
Nutritional status
Details
Effect of platinum-containing regimen combined with chemotherapy on the survival of elderly patients with advanced non-small cell lung cancer
Published on
Journal of Mathematical Medicine
2023,36(12):899-905.
2156 times
765 times
Xue-Xing WANG
Yuan HE
Jie CHU
Yu-Feng WANG
Non-small cell lung cancer
Retrospective cohort study
Chemotherapy
The elderly
Survival analysis
Details
Efficacy and safety of sindilizumab combined with intensity modulated radiotherapy and chemotherapy in patients with advanced cervical cancer
Published on
Frontiers in Pharmaceutical Sciences
2023,36(12):456-464.
1805 times
606 times
Jiang-Yue TANG
Lin WANG
Jing ZHANG
Rong REN
Ling CHEN
Advanced cervical cancer
Sindilimab
Intensity modulated radiotherapy and chemotherapy
Clinical efficacy
Security
Details
Clinical efficacy and safety evaluation of probiotic-assisted chemotherapy in patients with advanced colorectal cancer
Published on
Frontiers in Pharmaceutical Sciences
2024,27(2):295-301.
1729 times
659 times
YE Fan
LI Zhuo
HUANG Xing
XIAO Zhigang
Advanced colorectal cancer
Chemotherapy
Probiotics
Clinical efficacy
Safety
Details
PD-1 inhibitor combined with chemotherapy in the treatment of metastatic nasopharyngeal carcinoma: a case report
Published on
Journal of Mathematical Medicine
2024,37(5):392-397.
2164 times
765 times
CHENG Yanshuang
WANG Juan
JIN Jieying
WU Qiuji
ZHONG Yahua
Nasopharyngeal carcinoma
PD-1 inhibitor
Immunotherapy
Chemotherapy
Details
Changes of coagulation function before and after neoadjuvant chemotherapy in patients with ovarian cancer and their clinical significance
Published on
Frontiers in Pharmaceutical Sciences
2024,27(5):802-809.
2089 times
613 times
SHI Wan
YANG Yaxing
CHEN Chu
WANG Miao
WANG Yongfeng
WEI Xin
LEI Fang
Ovarian cancer
Neoadjuvant chemotherapy
Coagulation function
Platelets count
Effect
Details
Progress of clinical research on immunotherapy and antibody-drug conjugates for the treatment of triple-negative breast cancer
Published on
Frontiers in Pharmaceutical Sciences
2024,27(5):901-908.
2335 times
560 times
YANG Dan
WANG Jinxiu
MAO Dahua
Triple-negative breast cancer
Immunotherapy
Antibody-drug conjugates
Clinical trials
Immune checkpoint inhibitors
Chemotherapy
Details
Risk assessment and prediction model for capecitabine-induced chemotherapy-related adverse reactions in colorectal cancer patients
Published on
Frontiers in Pharmaceutical Sciences
2024,27(6):992-998.
2043 times
444 times
CHEN Shaobo
WU Xutao
QIU Wenhui
HU Tingting
Colorectal cancer
Capecitabine
Chemotherapy
-induced adverse efects
Risk prediction model
Details
Analysis of the prognostic value of NLR in the treatment of PD-1 inhibitors in patients with HER2-negative advanced gastric cancer
Published on
Frontiers in Pharmaceutical Sciences
2024,27(6):1063-1071.
2177 times
439 times
DOU Yalin
CHENG Weili
SUN Mingqi
WU Shuanghong
YANG Tingting
LI Dapeng
Advanced gastric cancer
Immunotherapy
Neutrophils/lymphocytes
Prognosis
Chemotherapy
human Epdermal growth factor receptor
Details
Cost-utility analysis of pembrolizumab combined with chemotherapy for advanced malignant pleural mesothelioma
Published on
Chinese Journal of Pharmacoepidemiology
2024,33(10):1107-1114.
1800 times
353 times
HU Yunjia
ZOU Keqing
HOU Yanhong
Pembrolizumab
Chemotherapy
Advanced malignant pleural mesothelioma
Partitioned survival model
Cost-utility analysis
Pharmacoeconomic evaluation
Details
Efficacy and safety of arterial interventional neoadjuvant chemotherapy for locally advanced cervical cancer in China: a Meta-analysis of randomized controlled trials and GRADE evidence score
Published on
Frontiers in Pharmaceutical Sciences
2024,28(3):497-506.
1679 times
237 times
ZHAO Li
PENG Lei
ZHANG Shaohua
YANG Chunyan
ZUO Manyun
YANG Hongmei
BIE Jun
Locally advanced cervical cancer
Neoadjuvant chemotherapy
Arterial interventional chemotherapy
Intravenous chemotherapy
Meta-analysis
Details
Influence of intestinal flora on the efficacy of chemotherapy and related adverse reactions in breast cancer
Published on
Chinese Journal of Pharmacoepidemiology
2025,34(1):94-98.
1078 times
132 times
ZHAO Yuting
YANG Yuchen
CAI Zhihui
Intestinal flora
Probiotics
Chemotherapy
Efficacy
Adverse drug reactions
Details
Construction and validation of a predictive model for the risk of myelosuppression after first-line chemotherapy in patients with advanced colorectal cancer
Published on
New Medicine
2025,35(1):33-40.
974 times
315 times
WANG Xuexing
ZHANG Rong
CHU Jie
LIU Zhijin
Colorectal cancer
Chemotherapy
Myelosuppression
Risk prediction models
Logistic regression analysis
Details
1
2
下一页